Company Description

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada.

The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products.

It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals.

ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

ANI Pharmaceuticals, Inc.

Country	United States
Founded	2001
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	642
CEO	Nikhil Lalwani

Contact Details

Address: 210 Main Street West Baudette, Minnesota 56623 United States
Phone	218 634 3500
Website	anipharmaceuticals.com

Stock Details

Ticker Symbol	ANIP
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001023024
CUSIP Number	00182C103
ISIN Number	US00182C1036
Employer ID	58-2301143
SIC Code	2834

Key Executives

Name	Position
Nikhil Lalwani	Chief Executive Officer
Stephen Carey	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Dec 17, 2024	144	Filing
Nov 26, 2024	144	Filing
Nov 20, 2024	8-K	Current Report
Nov 13, 2024	SC 13G/A	[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024	10-Q	Quarterly Report
Nov 8, 2024	8-K	Current Report
Sep 20, 2024	8-K	Current Report
Sep 16, 2024	8-K	Current Report
Aug 13, 2024	8-K	Current Report
Aug 8, 2024	8-K	Current Report

View All SEC Filings